DKSH begins tie-up with AMCo

PETALING JAYA: Market expansion services provider DKSH Malaysia Sdn Bhd has established a partnership with an international pharmaceutical company Amdipharm Mercury Company Ltd (AMCo) to market and distribute the company’s eye drop products in Malaysia.
In a statement released yesterday, it said DKSH Business Unit Healthcare has signed an agreement with AMCo to provide registration, marketing and sales, distribution and after-sales services for the company’s eye drop products, called Fucithalmic®, for hospitals, clinics and pharmacies in the country.
Fucithalmic® is an eye drop medicine used to treat a common infection of the eye called bacterial conjunctivitis, which is sold in over 90 countries worldwide.
DKSH Malaysia vice-president of health-care Dr Varun Sethi said the partnership with AMCo complements and enhances the group’s existing range of pharmaceutical brands, as well as demonstrates its capabilities and strength in pharmacy and medical channels.
DKSH, which is headquartered in Zurich, helps other companies and brands to grow their business in new or existing markets, with 750 business locations in 35 countries – 720 of them in Asia. In 2014, DKSH generated net sales of CHF 9.8 billion.